|
|
[ILMU MUDAH]: Apa pendapat anda tentang Vaccine untuk Covid-19?
[Copy link]
|
|
|
The pre-vaccination assessment is specifically for people with:
1. A weakened immune system (immunocompromised)
1.1 Cancer patients
1.2 Individuals with organ transplantation history
1.3 Individuals with chronic HIV infection
1.4 Individuals on immunosuppressant medication
2. A history of severe allergic reactions (anaphylactic)
2.1 Towards vaccines, medications or shots that may contain polyethylene glycol (PEG) or polysorbate
2.2 Reaction from unknown cause
2.3 After receiving first dose or within 72 hours from vaccine injection
2.4 Towards contents found in COVID-19 vaccine
3. Bleeding disorders
3.1 Individuals on medications that can cause bleeding or affect the body's ability to form clots
3.2 Haemophilia patients
There is no need to obtain a pre-vaccination assessment if you are not classified under the groups listed above.
The reasons for obtaining a pre-vaccination assessment are below:
1. To determine:
1.1 Vaccination eligibility/suitability
1.2 Suitable time for vaccination (if delay is required)
2. The doctor will also identify:
2.1 Type of vaccine
2.2 Most suitable time for vaccination
2.3 Vaccination location
The steps to obtain a pre-vaccination assessment is simple:
1. Consult your regular doctor or medical specialist
2. For issues where there is no follow-up treatment, such as severe allergies or no regular doctor visits, you may go to a nearby Klinik Kesihatan for further advice
3. A letter will be issued by the specialist who examined you. Please remember to bring the letter along on your vaccination day
Register for vaccination: https://vaksincovid.gov.my/en/guide
#LindungDiriLindungSemua |
This post contains more resources
You have to Login for download or view attachment(s). No Account? Register
x
Rate
-
1
View Rating Log
-
|
|
|
|
|
|
|
|
|
|
|
keypochino replied at 2-5-2021 02:29 PM
The pre-vaccination assessment is specifically for people with:
1. A weakened immune system (immuno ...
good one. Tq |
|
|
|
|
|
|
|
|
|
|
|
masa acute phase, Hep B ada ubatnya.. lepas tu kita wat follow up dan kita tgk viral copies byk mana
dan bergantung pada tu adalah lah regime2 yg Infectious Disease team akan guna untuk clear out the infection
|
|
|
|
|
|
|
|
|
|
|
|
ha ha jgn la takut2
gi je dapatkan vx tu
important
|
|
|
|
|
|
|
|
|
|
|
|
now dah tutup semua
irresponsible la mereka tu
byk menyusahkan masyarakat
|
|
|
|
|
|
|
|
|
|
|
|
ya it will be after a year
and possible also will need annual re-vaccination
yes, the efficacies of these vaccines will only be truly known after enough number of people get them to generate a useful statistical readings
|
Rate
-
1
View Rating Log
-
|
|
|
|
|
|
|
|
|
|
|
yeah sebab inlfuenzae viruses tu mutate every year
so very year docs and nurses are encourage to take these flu jabs
so the government provide these for free to encourage uptake
vulnerable patients are offered these too
|
Rate
-
1
View Rating Log
-
|
|
|
|
|
|
|
|
|
|
|
kelatam sempat jadi number 1?
eh tak lah..2nd je kan
tapi kelate mmg tak moh sgt dgr orang kata
|
|
|
|
|
|
|
|
|
|
|
|
ameen moga2 you all selamat
terima kasih mengingat kan saya
ya, spread in the community ni mmg ngeri
tak hilang dalam community tu melainkan: yg kena tu mati dan takleh lagi spread; or sebahagian besar org dalam community itu dah develop immunity due to exposure to covid-19 ie herd immunity
|
|
|
|
|
|
|
|
|
|
|
|
teruk lah depa tu
tak jaga SOP langusng
|
|
|
|
|
|
|
|
|
|
|
|
Nanti nak inform kolig, mak dia  tq...ni dah cuti raya...minggu dpn baru jumpa kat opis...
|
|
|
|
|
|
|
|
|
|
|
|
Terlepas hari tu derang offer 20 suntikan...huhu...bz bebeno...tunggu dipanggil...nephew yg JPAM dah dapat dulu
|
|
|
|
|
|
|
|
|
|
|
|
Tu le gedebe hihi...ni dah 4,000++ kes...jgn le PKP 1 Malaysia...
|
|
|
|
|
|
|
|
|
|
|
|
Semua dah alpa sebenarnya...kakak siap tanya boleh tak pakai balik baju yg dah pakai tadi...huhu...sabo je le...
|
|
|
|
|
|
|
|
|
|
|
|
i see, yes indeed but here the uptake of vaccine depend on how often we talk about it. But for covid-vx im sure numbers are increasing dah..tak tertengok dah i, infact yang goverment invite voluntering those nak get the jab pun dah full booked (Astra Zeneca)
|
|
|
|
|
|
|
|
|
|
|
|
now kes tinggi more to community - sporadik kes.
i dah boring monitor covid, just ensure sop sahaja. We are born with brain so all of us should know how crucial this is. Sadly masih ramai take it easy je such an ignorance human being. Most of us yang directly involved we are kinda of like pissed off , frustrated and exhausted. Imagine those frontlines yang work 24/7 for covid. My lab people pun kesian sehari berapa ratus or ribu sample kena run. .x balik umah dia.
|
|
|
|
|
|
|
|
|
|
|
|
Salam dr @ipes2
Sy nak tanya pendapat dr berkenaan vaksin ni. 1 st dose inject 4/3/21. 5 hari lps vaksin sy start gatal bahagian tubuh. Die gatal x menentu. Sebelum ni, sy tak pernah jadi macam ni. Sy ade gak allergy seafood tp last 20 years ago. Kalau biase sy bersin dan gatal mata ja. Ni sy pelik lps vaksin bdn saya mudah gatal. Sy pergi hospital die bagi ubat gatal loratadine, chloropheniramine , piriton dan ubat sapu, Dr kate macam pelik sbb byk hari dh. Kalau ade pn delayed symptom. Gatal ok kejap. Pastu datang balik. Sy pergi klinik Dr inject. Lps 2 3 hari ok sket. 25/3 sy inject 2nd dose. Sy xde gatal pn. Cume lps 22/4 sy start gatal balik. Sy ade makan seafood bln puase tu. Sy telan chloropheniramine masih gatal. Last2 die berhenti sendiri. 3 4 hari lps tu sy start gatal balik, ade mata bengkak dan sampai skarang gatal on off pastu certain area tubuh je gatal. Sy telan loratadine je skarang. Sy nak tanye dr @ipes2 adekah simptom gatal on off sy ni ade kaitan vaksin pfizer yg disuntik? Kalau tak, apa pandangan dr, sy patut jumpa pakar kulit ke? Ke sebab cuaca skarang kulit jd sensitif?
Tq dr. |
|
|
|
|
|
|
|
|
|
|
|
Dari web KKM
MOH Response to Claims Regarding Use of Ivermectin Could Prevents All COVID-19 Deaths
BY DG OF HEALTH ON MAY 16, 2021
MOH Response to Claims Regarding Use of Ivermectin Could Prevents All COVID-19 Deaths
Ivermectin is an anti-parasitic drug mostly used in veterinary medicine, especially treating worm infestations. In April 2020, researchers using laboratory methods showed that Ivermectin can also inhibit the replication of SARS-CoV-2, the novel virus that causes COVID-19 illness. Since then, many authors relying on findings from small studies and case series have suggested the potential use of Ivermectin against COVID-19. Yet the recommendation for the ‘off-label’ use of Ivermectin in COVID-19 has been controversial since the beginning.
Firstly, many Ivermectin studies had limitations including small sample size, non-controlled study designs or that the drug was used as add-on treatment. Therefore this had confounded the effect of Ivermectin, if any. In January 2021, a placebo-controlled randomized trial involving 24 non-severe COVID-19 patients did not manage to show reduction in the proportion of PCR positive patients at day 7 post Ivermectin 400 mcg/kg single oral dose treatment. The authors of the pilot study, published in EClinical Medicine (Lancet), opinionated that larger trials may be needed to understand the effects of Ivermectin. In March this year, the Journal of American Medical Association (JAMA) published a randomised-controlled trial involving 476 adults with mild COVID-19 disease given a 5-day course of Ivermectin. The results showed that there was no significant improvement in COVID-19 symptoms resolution time. Whilst Ivermectin may have some anti-viral and anti-inflammatory effects, the evidence remains inconclusive.
Regulatory bodies including the US FDA and the European EMA, after evaluating these studies, have concluded that there was insufficient evidence to support the use of Ivermectin as treatment of COVID-19. The WHO also issued guidelines against the routine use of Ivermectin in the treatment of COVID-19 except in clinical trial settings.
Regardless of these decisions, support for Ivermectin as a “miracle drug” is being circulated by several NGOs and by those who want the drug repurposed against COVID-19. Recently, the Coalition on Integrity of Vaccines & Drugs Against COVID-19 (CIVDAC) Malaysia, surmised that no one would die from COVID-19 if only Ivermectin is given from the onset of one’s illness. Specifically, the CIVDAC cites scientific proof on the utility of Ivermectin as recommended by some experts from US-based Front Line COVID-19 Critical Care (FLCCC). Yet, the synthesis of the evidence includes inferences only from preliminary reports of work without peer review, and opaqueness for risk of bias assessment of studies included in the body of evidence.
The Ministry of Health Malaysia has initiated a randomised clinical trial to repurpose Ivermectin and evaluate its efficacy and safety in high risk COVID-19 patients (NMRR-21-155-58433). The trial will enrol 500 COVID-19 patients admitted to 12 MOH hospitals. Through this study, MOH hopes to have a correct perspective on the clinical effectiveness of Ivermectin. Although Malaysia’s risk for COVID-19 may be heightened at the moment, we must keep in mind that in all circumstances, we need to take steps necessary to figure out what really works. Without the benefit of evidence from well-designed clinical trials, the Ministry of Health Malaysia is not yet able to endorse Ivermectin to prevent or treat COVID-19 illness. Science remains the best weapon against the SARS-Cov-2 virus, not circumstantial hype. |
Rate
-
1
View Rating Log
-
|
|
|
|
|
|
|
|
|
|
|
This is the advisory on COVID-19 vaccines suitability for pregnant and lactating mothers as of 17th May 2021.
This information will be updated from time to time once more information and data are available.
Register for vaccination: https://vaksincovid.gov.my/en/guide
#LindungDiriLindungSemua |
This post contains more resources
You have to Login for download or view attachment(s). No Account? Register
x
Rate
-
1
View Rating Log
-
|
|
|
|
|
|
|
|
|
|
|
very important info Keypo
useful for forumers to know
|
|
|
|
|
|
|
|
|
|
| |
|
Post time 2-5-2021 02:29 PM
Author
Post time 8-5-2021 02:00 PM
Post time 14-5-2021 08:15 PM
